The early results from the ReCET study were shared at Digestive Disease Week in 2023 and have sparked excitement in the ...

Last month, we wrote about successful trials of a 'once-a-week' insulin shot for type 1 and type 2 diabetics. And in August, we learned about new tech to detect diabetes from the pitch of your ...

Phase 3 data support use of the oral non-peptide small molecule as potential first-line type 2 diabetes treatment, ...

The endocrinologist and researcher was one of several investigators who presented Phase 3 clinical trial results at the 85th Scientific Sessions of the American Diabetes Association for a long-lasting ...

A cure for diabetes has been top of mind for many that live with the conditions under the term’s umbrella. But type 1 ...

One of the more difficult decisions for patients with poorly controlled type 2 diabetes, as well as for their clinicians, is ...

At the diabetes conference, Eli Lilly presented results of a phase 1 trial of its experimental drug, eloralintide. Unlike GLP ...

Considered a disease of middle-aged and older adults until the late 20th century, type 2 diabetes has risen markedly ...